BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, April 24, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 14, 2009

View Archived Issues

An exploratory memantine trial in amyotrophic lateral sclerosis produces discouraging results

Read More

KNS-760704 is well tolerated and may be beneficial in treating amyotrophic lateral sclerosis

Read More

Recent studies of dengue vaccines presented at the ASTMH meeting

Read More

NanoPacific Holdings acquires license from UCLA for supramolecular nanoparticles

Read More

CSL and Sanofi Pasteur are developing vaccine to treat gum disease

Read More

Sanofi Pasteur expands global clinical program of its dengue vaccine

Read More

GSK initiates second pivotal phase III trial of darapladib

Read More

QLT reports results of EVEREST trial of Visudyne(R) in polypoidal choroidal vasculopathy

Read More

Repligen reports phase III trial results of RG-1068 in pancreatic imaging

Read More

Targacept initiates phase II proof-of-concept trial of TC-5619 in schizophrenia

Read More

Algeta initiates phase III ALSYMPCA trial of Alpharadin in CRPC in the U.S.

Read More

GSK and Intercell collaborate to develop needle-free, patch-based vaccines

Read More

Daiichi reports on phase III trial of edoxaban to prevent postoperative venous thromboembolism

Read More

Johnson & Johnson reports results from phase III trial of Invega Sustenna in schizophrenia

Read More

AstraZeneca describes TAK1 inhibitor with potential for treating mantle cell lymphoma

Read More

Basilea's Toctino recommended for approval for hand eczema in additional E.U. countries

Read More

NDDPX-08 increases survival and delays disease progression in mouse model of ALS

Read More

European Commission grants marketing authorization to Pfizer's Prevenar 13 vaccine

Read More

MediGene presents update on clinical development of EndoTAG-1 and RhuDex

Read More

University of California, Oakland discloses neuraminidase inhibitors for avian influenza

Read More

Arpida completes merger with Evolva

Read More

Novartis presents novel ALK inhibitors for treatment of pulmonary hypertension

Read More

Takeda identifies novel kinase inhibitors for the treatment of cancer

Read More

Aztreonam for inhalation solution recommended for approval by FDA advisory committee

Read More

Cubist Pharmaceuticals to acquire Calixa Therapeutics

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 23, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 21, 2026
  • Green arrow on blue abstract background

    Psychedelic space expanding on Trump’s EO

    BioWorld
    Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
  • Illustration of metastatic cancer

    At AACR: Epigenetic fingerprints in metastases track tumor origin

    BioWorld
    When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
  • Illustration of human face that looks abstract and digital

    AACR 2026: The age of agentic AI in oncology

    BioWorld Science
    New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing